Extravasation injury as a result of VAD chemotherapy.
Maslovsky
Igor
I
Internal Medicine Department, Barzilai Medical Center, Ashkelon, Israel. igorgn@012.net.il
D000368:Aged; D000931:Antidotes / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D003907:Dexamethasone / Q000009:adverse effects; D004317:Doxorubicin / Q000009:adverse effects; D042241:Early Diagnosis; D005119:Extravasation of Diagnostic and Therapeutic Materials / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy*; D006801:Humans; D008297:Male; D009101:Multiple Myeloma / Q000188:drug therapy; D009730:Nursing Assessment; D011929:Razoxane / Q000627:therapeutic use; D017592:Skin Care / Q000379:methods* / Q000451:nursing; D014750:Vincristine / Q000009:adverse effects
D000931:Antidotes; D011929:Razoxane; D014750:Vincristine; D003907:Dexamethasone; D004317:Doxorubicin